Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.
复制标题
DOI:
10.3349/ymj.2020.61.10.860
复制
发表时间:
2020-10
影响因子:
2.4
通讯作者:
Kim MC
中科院分区:
文献类型:
--
作者:
Kang MK;Park JG;Kim MC
Non-alcoholic fatty liver disease (NAFLD) is independently associated with the development of atrial fibrillation (AF). However, the association of AF with advanced liver fibrosis, which is related to all-cause, cardiovascular, and liver-related mortality, has not been established in NAFLD patients. We aimed to investigate the association between AF and advanced liver fibrosis in NAFLD patients. Out of 53704 adults who participated in the health check-up program, 6293 subjects aged 35 years and older were diagnosed as NAFLD using ultrasound. The stage of liver fibrosis was assessed based on the newly adjusted NAFLD fibrosis score (NFS) and Fibrosis-4 (Fib-4) Index, which were used to determine the low and high cut-off values (COVs). Of 6293 patients with NAFLD, 59 (0.9%) were diagnosed with AF. Patients with AF were older (52.0 vs. 64.6 years, p<0.001), had higher body mass index (25.2 vs. 26.6 kg/m2, p<0.001), and had bigger waist circumference (84.0 vs. 89.9 cm, p<0.001) than those without AF. In NAFLD patients, AF was independently associated with advanced liver fibrosis, assessed using both COVs of NFS [low-COV group: final adjusted odds ratios (aORs)=2.85, p=0.004; high-COV group: ORs=12.29, p<0.001). AF was independently associated with advanced liver fibrosis, assessed using both COVs of Fib-4 (low-COV group: aORs=2.49, p<0.001; high-COV group: aORs=3.84, p=0.016). AF is independently associated with advanced liver fibrosis in patients with NAFLD.
登录
查看更多内容
影响因子:
2.8
作者:
Buzzetti E;Lombardi R;De Luca L;Tsochatzis EA
通讯作者:
Tsochatzis EA
影响因子:
3.7
作者:
Liu YC;Hung CS;Wu YW;Lee YC;Lin YH;Lin C;Lo MT;Chan CC;Ma HP;Ho YL;Chen CH
通讯作者:
Chen CH
影响因子:
3.7
作者:
Lee YH;Bang H;Park YM;Bae JC;Lee BW;Kang ES;Cha BS;Lee HC;Balkau B;Lee WY;Kim DJ
通讯作者:
Kim DJ
影响因子:
6.1
作者:
Kirchhof, Paulus;Benussi, Stefano;Zeppenfeld, Katja
通讯作者:
Zeppenfeld, Katja
影响因子:
29.4
作者:
Angulo P;Kleiner DE;Dam-Larsen S;Adams LA;Bjornsson ES;Charatcharoenwitthaya P;Mills PR;Keach JC;Lafferty HD;Stahler A;Haflidadottir S;Bendtsen F
通讯作者:
Bendtsen F